Medindia

X

Transdermal Drug Patches to 2022

Thursday, April 21, 2016 Cancer News J E 4
Advertisement

LONDON, April 20, 2016 /PRNewswire/ -- Patient-centric Syringe & Injector Design Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2022.Market-driven Product StrategiesA longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.What You Will Learn- What are the current transdermal drug patch markets and products, and what is the market potential for existing and probable future products? - What is the impact of patch designs, technologies and patch development issues on commercialization? - Who are the leading patch manufacturers and third-party transdermal supply chain companies?- What is the current product and competitive landscape, and what are the details of the numerous products across the various patch product categories and markets?- What is the size of the market now, and how will it change in the next seven years to 2022? - Who are the transdermal drug patch product providers, and what are their product development activity, and strategies?- What is the market impact of economic, technology, and regulatory factors?Download the full report: https://www.reportbuyer.com/product/1941669/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/transdermal-drug-patches-to-2022-300254904.html

SOURCE ReportBuyer

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Heidi Michele Davis is recognized by Continental W...
S
Frontier Pharma: Ovarian Cancer Report - What Are ...